Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€97.50

€97.50

0.100%
0.1
0.100%
€101.00
 
19.04.24 / Tradegate WKN: 531370 / Name: Carl Zeiss Meditec / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Description Carl Zeiss Meditec

Carl Zeiss Meditec is a leading manufacturer of medical technology that specializes in providing visualization systems and medical devices for ophthalmology, neurosurgery, and ENT (ear, nose, and throat) surgeries. The company is headquartered in Jena, Germany, and has a range of products that are sold globally in more than 135 countries. Their products include surgical microscopes, ophthalmic lasers, diagnostic systems, intraocular lenses, and equipment for minimally invasive surgery. Carl Zeiss Meditec is a publicly traded company and is listed on the Frankfurt Stock Exchange under the ticker symbol AFX.

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Carl Zeiss Meditec AG is only available for our menbers.
Not a member yet? Sign up for free!

Competitors of Carl Zeiss Meditec

Carl Zeiss Meditec is a leading German medical technology company specializing in optical and optoelectronic systems, surgical microscopes, and medical visualization solutions. Its main competitors are:

1. Alcon Inc.: A global leader in eye care and cataract surgery, Alcon Inc. designs, develops, and manufactures innovative products for ophthalmology, including surgical equipment, contact lenses, and intraocular lenses.

2. Bausch Health Companies Inc.: Bausch Health Companies, formerly known as Valeant Pharmaceuticals, is a multinational specialty pharmaceutical and medical device company. It offers a wide range of products for eye health, including contact lenses, surgical products, and over-the-counter eye drops.

3. EssilorLuxottica SA: EssilorLuxottica is a global leader in the eyewear industry, designing, manufacturing, and distributing high-quality eyewear products for consumers worldwide. It offers a wide range of solutions for eye health, including prescription eyeglasses, contact lenses, and surgical equipment.

4. Johnson Johnson: Johnson Johnson is a multinational healthcare conglomerate with a broad range of products, from pharmaceuticals to medical devices to consumer health products. Its Vision Care division offers contact lenses, intraocular lenses, and surgical equipment for eye care.

5. Novartis AG: Novartis is a global pharmaceutical and healthcare company that offers a wide range of products, from prescription drugs to generic medicines to innovative medical devices. Its Alcon division offers products for eye health, including contact lenses, intraocular lenses, and surgical equipment.

Financial data and news for Carl Zeiss Meditec

sharewise wants to provide you with the best news and tools for Carl Zeiss Meditec, so we directly link to the best financial data sources.

News

EQS-News: Carl Zeiss Meditec achieves slight revenue growth in first quarter of 2023/24http://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
EQS-News: Carl Zeiss Meditec achieves slight revenue growth in first quarter of 2023/24
EQS-News: Carl Zeiss Meditec achieves slight revenue growth in first quarter of 2023/24
EQS-Adhoc: Carl Zeiss Meditec AG agrees to launch share buyback program with volume of up to €150mhttp://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
EQS-Adhoc: Carl Zeiss Meditec AG agrees to launch share buyback program with volume of up to €150m
EQS-Adhoc: Carl Zeiss Meditec AG agrees to launch share buyback program with volume of up to €150m
EQS-News: U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISShttp://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
EQS-News: U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS
EQS-News: U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS
EQS-News: Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)http://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
EQS-News: Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)
EQS-News: Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)
EQS-Adhoc: Carl Zeiss Meditec AG announces agreement to acquire D.O.R.C. http://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
EQS-Adhoc: Carl Zeiss Meditec AG announces agreement to acquire D.O.R.C.
EQS-Adhoc: Carl Zeiss Meditec AG announces agreement to acquire D.O.R.C.
EQS-News: Carl Zeiss Meditec increased revenue in fiscal year 2022/23 by around 10 percenthttp://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
EQS-News: Carl Zeiss Meditec increased revenue in fiscal year 2022/23 by around 10 percent
EQS-News: Carl Zeiss Meditec increased revenue in fiscal year 2022/23 by around 10 percent